October 07, 2025

EASO Issues Obesity Pharmacotherapy Guidance

EASO framework guides obesity drug selection by weight loss effect and complication focus.

Conexiant

October 03, 2025

Pediatric ALL or Lymphoblastic Lymphoma: Reduced Induction Dexamethasone and High-Dose Methotrexate

UK investigators found that a shorter duration of induction dexamethasone did not reduce steroid-related toxicity, and high-dose methotrexate did not reduce CNS relapse among patients younger than age...

The ASCO Post

October 01, 2025

PET/CT Often Misdiagnoses Rare Lymph Node Disease

Imaging suggested lymphoma in one-third of histiocytic necrotizing lymphadenitis cases; biopsy required for diagnosis.

Conexiant

September 30, 2025

Med Diet: New Angle on Gum Disease?

Study links red meat consumption and poor diet quality to severe gum disease in 195 UK patients.

Conexiant

September 29, 2025

FDA Expands Options for Pediatric Psoriasis, PsA

The FDA has approved the first IL-23 inhibitor for pediatric patients with plaque psoriasis and psoriatic arthritis.

Conexiant

September 26, 2025

FDA Approves First Once-Daily Oral Therapy for Acromegaly

Once-daily paltusotine offers an oral alternative to monthly injections for eligible adults.

Conexiant

September 24, 2025

Medical Oddities: Why Time on the Toilet Matters

From toilets to tea, bones to bullies, medicine’s strangest corners show us where science loves to surprise.

Conexiant

September 23, 2025

Juvenile SLE: Feasibility of Early Glucocorticoid Tapering

Early glucocorticoid tapering in juvenile systemic lupus erythematosus is feasible without added flare risk, though anti-double-stranded DNA positivity signals higher relapse odds.

Conexiant

September 22, 2025

Staffing Falls, Deaths Rise Post-Acquisition

Among Medicare patients, ICU stays shorten and transfers rise following private-equity acquisitions.

Conexiant